Who Owns CBIO?

Crescent Biopharma, Inc. — Institutional Ownership & 13F Holdings

$25.18

+0.39 (+1.55%)

Market Cap

$683.4M

Shares Outstanding

27,556,767

Institutional Holders

0

Total Inst. Value

$0

% of Float Held

QoQ Holder Change

Frequently Asked Questions

How many institutional investors hold CBIO?

As of the latest quarter, 0 institutional investors report holding CBIO (Crescent Biopharma, Inc.) in their 13F filings.

Are institutions buying or selling CBIO?

This quarter, 0 institutions opened new positions in CBIO and 0 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.